## APO: Apollo Global Management, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 1.59 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (45% of avg), momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($139.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Capricorn Fund Managers Ltd Acquires Shares of 13,307 Apollo Global Management Inc. $APO**
- Source: MarketBeat | 20251228T100919 | Bullish | Relevance: 100%
- Capricorn Fund Managers Ltd has acquired 13,307 shares of Apollo Global Management Inc. (NYSE:APO) in Q3, valued at approximately $1.77 million. This new position contributes to the significant institutional ownership of APO at 77.06%, with other major firms also increasing their stakes. Analysts maintain a "Moderate Buy" rating for the stock, with a consensus target price of $166.23.

**2. AW Top 10 reads for December**
- Source: Alternatives Watch | 20251230T214451 | Somewhat-Bullish | Relevance: 84%
- This article lists the top 10 most-read stories on Alternatives Watch for December, reflecting diverse alternative investment activities. Key themes include energy transition deals, real estate acquisitions, venture capital raises for AI, and pushes to democratize private markets. The list highlights significant transactions and trends shaping the alternative investment landscape.

**3. Abacus Global Management to transfer listings from Nasdaq to NYSE By Investing.com**
- Source: Investing.com Nigeria | 20251229T220838 | Neutral | Relevance: 64%
- Abacus Global Management, Inc. announced its decision to transfer the listings of its common stock and 9.875% Fixed Rate Senior Notes due 2028 from the Nasdaq Capital Market (NASDAQ:ABL, NASDAQ:ABLLL) to the New York Stock Exchange. Trading on the NYSE is expected to commence on Tuesday, December 30, 2025, under new symbols NYSE:ABX and NYSE:ABXL. The company, which qualifies as an emerging growth company, has shown significant financial growth, including a 124% increase in total revenue for Q3 2025.

**4. 14 High Growth Large Cap Stocks to Buy Right Now**
- Source: Insider Monkey | 20251228T124500 | Somewhat-Bullish | Relevance: 63%
- This article presents a list of 14 high-growth large-cap stocks. It highlights HubSpot, Inc. (NYSE:HUBS) as an example, detailing its market capitalization, hedge fund interest, revenue growth, analyst ratings, and its strategic emphasis on AI integration despite recent stock underperformance. The article suggests that HubSpot's AI-powered features could lead to improved customer retention and strong growth potential.

**5. 14 High Growth Large Cap Stocks to Buy Right Now**
- Source: Insider Monkey | 20251228T124500 | Neutral | Relevance: 61%
- The article highlights Axon Enterprise, Inc. (NASDAQ: AXON) as a high-growth large-cap stock, detailing a recent price objective reduction by Morgan Stanley analyst Meta Marshall while reiterating an "Overweight" rating. It emphasizes Axon's strategic focus on AI integration in law enforcement technology and its expanding product ecosystem, which strengthens customer retention. The company also announced a redemption notice for its convertible senior notes due in 2027.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $172 | $159 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($1.31M) |
| Sells | 9 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 8.2% (+3.0%)
- Blackrock Inc.: 5.8% (+0.1%)
- Capital World Invest: 4.9% (-3.6%)
- FMR, LLC: 4.3% (+38.2%)
- JPMORGAN CHASE & CO: 3.5% (+270.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.1% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.59 elevated, pricing in significant growth expectations. Forward P/E 15.8x attractive for 16% earnings growth. Quality metrics strong (margin 16%). Analyst sentiment positive (1 raises, avg +8%). Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.8B |
| Beta | 1.60 |
| 52W Range | $102.58 - $174.91 |
| Short Interest | 6.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.59 |
| Forward P/E | 15.8 |
| Current P/E | 18.3 |
| YoY Growth | 15.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.0% to 0.9% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.7%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 45% of 20MA suggests lack of conviction. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.93% (CS: 65) | Neutral |
| RSI_14 | 60.5 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.085x | Above |
| vs SMA200 | 1.074x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $146.11
- **Stop Loss:** $139.55 (4.5% risk)
- **Target:** $152.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 125
- **Position Value:** $18,263.75
- **Portfolio %:** 18.26%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-04 (Est: $2.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.90 | $2.17 | +14.2% |
| 2025Q2 | $1.84 | $1.92 | +4.2% |
| 2025Q1 | $1.84 | $1.82 | -1.3% |
| 2024Q4 | $1.89 | $2.22 | +17.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*